In a prospective community-based cohort, Lp(a) ≥50 mg/dL was associated with higher stroke risk in those without AF, but not in those with AF, nor with an elevated risk of AF.
In heart failure patients with a reduced EF, paroxysmal AF and new onset AF were associated with a greater risk of adverse outcomes, including HF hospitalization and stroke, but not mortality.
KardiaBand evaluates heart rate and physical activity, and instantly pushes notifications to take an EKG, which can be recorded in 30 second with its integrated sensor.
AHA 2017 The TNT-POAF study evaluated botulinum toxin as a way to modulate autonomous nervous system tone, to reduce post-operative AF. Time to first episode of AF and the incidence of POAF were numerically lower, but no significant improvements were seen.
AHA 2017 Neurotoxin injection yielded numerically lower risk of POAF in TNT-POAF study, along with a shorter duration of first POAF episode, but the study may have been underpowered.
In a large retrospective cohort study, the risk of dementia was higher without oral anticoagulant treatment in patients with AF, compared with AF patients receiving oral anticoagulation.
An analysis of the REVEAL AF study, demonstrated a substantial incidence of previously undiagnosed AF when insertable cardiac monitors were used for 18 to 30 months in patients at high risk for AF and stroke.
AF patients not taking OAC due to a previous bleeding event have a considerably higher risk of ischemic and hemorrhagic events and death, particularly with a history of intracranial hemorrhage.
a concentration of 400 pg/mL, any given concentration of NT-proBNP had a similar predictive value for adverse outcomes in HFrEF patients with and without AF.
In the AFFIRM study, SBP variability was inversely associated with the quality of anticoagulation control in AF patients, and increasing SBP variability was associated with a higher risk of major adverse clinical outcomes.
Considering the close relationship between hypertension and arrhythmias, the EHRA and ESC council on hypertension teamed up with other international societies to compose management recommendations.
ESC 2017 Fewer major bleedings with dual therapy of dabigatran and platelet inhibitor than with triple therapy with warfarin, platelet inhibitor and aspirin, in AF patients receiving a stent in RE-DUAL PCI..